38 companies oppose OKXICE tokenized stocks amid Nasdaq lobbying claims

Nasdaq has reportedly encouraged companies listed on its exchange to oppose tokenized trading of their shares through OKXICE, as the number of corporate objections to the proposed blockchain stock market reached 38. Summary Nasdaq representatives reportedly encouraged listed companies to object to tokenized trading through OKXICE. The venture’s October 28 notice identifies 38 objecting companies, including Walmart, Eli Lilly, Carnival and Cigna. Nasdaq declined to address the allegations directly, reaffirming support for its own issuer-focused tokenization model. SEC rules give companies 30 days to object to unaffiliated third-party tokenization on a particular venue. Nasdaq is developing a separate model with Kraken, while Canton Strategic plans a November 2 launch through TSV. An executive at a Nasdaq-listed company said an exchange representative contacted the company and suggested filing an objection, according to Jacquelyn Melinek. The representative reportedly offered to arrange a call explaining the reasons for opposing the proposed trading venue. The allegation surfaced as OKXICE, a venture between cryptocurrency exchange OKX and New York Stock Exchange parent Intercontinen...